The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.00
Bid: 60.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.333%)
Open: 61.00
High: 61.00
Low: 61.00
Prev. Close: 61.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

28 Nov 2012 07:00

RNS Number : 1565S
IPPlus PLC
28 November 2012
 



28 November 2012

 

IPPlus plc

(the "Company" or the "Group")

 

Grant of Performance Related Options

 

IPPLUS PLC announces that on 27 November 2012 the Company granted performance related options over a total of 700,000 Ordinary Shares of 1p each in the capital of the Company ("Ordinary Shares") (the "2012-2015 Awards") in accordance with the recommendations of the Company's Remuneration committee.

 

The 2012-2015 Awards relate to a performance period beginning on 1 July 2012 and ending on 30 June 2015 and, assuming certain performance targets are met, will ordinarily vest on 13 September 2015 (or such later date as the Company publishes its annual results for the year ending 30 June 2015).

 

The exercise of options granted under the 2012-2015 Awards are subject to the Group's consolidated profit before tax for the financial year ending 30 June 2015 reaching certain specified figures. The Exercise Price for the options granted under the 2012-2015 Awards is 1p per Ordinary Share.

 

These arrangements have been designed to align management and employee interests with those of the Company's shareholders.

 

As part of the 2012-2015 Awards, options were granted to the following Executive Directors:

 

Director

Position

Number of options over Ordinary Shares granted

 

Exercise Price

Market Price at Date of Grant

William Catchpole

CEO

100,000

1p

16.375p

 

R. Stuart Gordon

CFO

100,000

1p

16.375p

 

Geoffrey Forsyth

CTO

100,000

1p

16.375p

 

 

The 2012-2015 Awards are subject to the achievement of performance conditions as specified by the Remuneration Committee and are subject to claw back provisions in certain circumstances.

 

Following the 2012-2015 Awards, the above Directors are interested in the following Ordinary Shares and options over Ordinary Shares in the Company:

 

Director

Number of Ordinary Shares held

Percentage of voting rights in the Company

 

Total options over Ordinary Shares held

Option exercise price

Expiry date of options

William Catchpole

2,506,124

7.89%

101,508

100,000

1p

1p

28 June 2022

26 November 2022

R. Stuart Gordon

897,039

2.82%

101,508

100,000

1p

1p

28 June 2022

26 November 2022

Geoffrey Forsyth

942,657

2.97%

101,508

100,000

1p

1p

28 June 2022

26 November 2022

 

The Company has 31,771,178 Ordinary Shares in issue and a total of 1,334,424 options over Ordinary Shares including the amounts held by the Directors above.

 

 

For further details, please contact:

 

IPPlus plc

William Catchpole - Chief Executive Officer

R Stuart Gordon - Chief Financial Officer

 

+44 844 544 6800

N+1 Singer (NOMAD & Broker)

Aubrey Powell / Alex Wright

+44 20 7496 3000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBDBDSDBGDR
Date   Source Headline
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.